Piper Sandler Maintains Kenvue(KVUE.US) With Buy Rating
Johnson & Johnson Makes $15 Billion Bet on Mental-health Drugs
Kenvue Stock Still Has 'Ample Room': Piper Sandler
Kenvue Analyst Ratings
Piper Sandler Maintains Kenvue(KVUE.US) With Buy Rating, Maintains Target Price $26
Piper Sandler Upgrades Kenvue(KVUE.US) to Buy Rating, Raises Target Price to $26
Express News | Kenvue Inc : Piper Sandler Raises to Overweight From Neutral
5 Value Stocks That Could Get a Bump From Activist Investors -- Barrons.com
Kenvue Inc.'s (NYSE:KVUE) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
Is Kenvue Inc. (KVUE) the Best New Stock to Buy According to Hedge Funds?
Unusual Options Activity: ANET, MSTR and Others Attract Market Bets, ANET V/OI Ratio Reaches 138.7
EST Dec 27th Morning Delivery - In the last two hours of trading, 10 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options trends.
FDA Proposes Testing Talc Products for Asbestos: Report
Unusual Options Activity: AMCR, KVUE and Others Attract Market Bets, AMCR V/OI Ratio Reaches 599.2
EST Dec 20th Closing Delivery - In the last three hours of trading, 10 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options
After GE's Spinoff Success, What's Next for Honeywell, FedEx
Peering Into Kenvue's Recent Short Interest
Daily short sale tracking: Warner Bros Discovery's short volume increased by 10 million, with a short sale ratio of 16%
Warner Bros Discovery(WBD.US) ranked top of the list had the largest change in short volume (10.01 million shares), and the short volume ratio of South Bow(SOBO.US) reached 58.62%. See more about the top 10 list of short selling volume changes in the latest trading day of the US stock market.
Jefferies Maintains Kenvue(KVUE.US) With Buy Rating, Maintains Target Price $27
Kenvue, Inc.: Strategic Growth Drivers and Market Positioning Justify Buy Rating
Kenvue Initiated at Equal-Weight by Barclays
Barclays Maintains Kenvue(KVUE.US) With Hold Rating, Maintains Target Price $23